EcoDrugPlus

Ensembl ID : ENSUAMG00000013016
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSUAMG00000011255
Gene Symbol: -
Cross references: -
108 Possible Orthologues:

Ensembl ID : ENSUAMG00000011253
Gene Symbol: -
Cross references: -
108 Possible Orthologues:

Ensembl ID : ENSUAMG00000010492
Gene Symbol: -
Cross references: -
152 Possible Orthologues:

Ensembl ID : ENSUAMG00000018141
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSUAMG00000010431
Gene Symbol: -
Cross references: -
246 Possible Orthologues:

Ensembl ID : ENSUAMG00000008684
Gene Symbol: -
Cross references: -
135 Possible Orthologues:

Ensembl ID : ENSUAMG00000018296
Gene Symbol: -
Cross references: -
348 Possible Orthologues:

Ensembl ID : ENSUAMG00000008236
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSUAMG00000008233
Gene Symbol: -
Cross references: -
194 Possible Orthologues:

Ensembl ID : ENSUAMG00000007997
Gene Symbol: -
Cross references: -
65 Possible Orthologues:

Ensembl ID : ENSUAMG00000007912
Gene Symbol: -
Cross references: -
151 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).